Medicare weight-loss drug coverage, BBBA changes, and medicine at 250

This week’s medical news recap focused on three broad themes: Medicare’s first step toward helping pay for weight-loss GLP-1 drugs, the first year of the One Big Beautiful Bill Act and its health care effects, and a look at how American medicine has changed by the country’s 250th anniversary.

Each story points to a different pressure facing physicians and patients. One involves a new temporary Medicare demonstration that changes how prior authorization is handled. Another centers on payment, coverage, and eligibility changes that are still moving into place after a major federal law took effect. The third reflects on how far medicine has progressed since the founding era, while noting that some business-of-medicine concerns remain familiar.

Medicare begins covering weight-loss drugs for the first time

Medicare started helping pay for GLP-1 drugs prescribed solely for weight loss on July 1 through a temporary demonstration known as the Medicare GLP-1 Bridge. The program creates a flat $50 monthly copay for patients, regardless of income, and marks the first time Medicare has begun covering these drugs for this purpose.

The process is different from usual Part D coverage. Prior authorization does not go through the beneficiary’s Part D plan. Instead, it is sent to a single central CMS processor that most practices have not used. The article said this change is likely to bring early delays and shift more of the administrative burden onto prescribers.

Eligibility is based on a patient’s BMI and diagnosis at the time GLP-1 therapy began. Patients already receiving a GLP-1 through Part D do not qualify for the bridge. The recap noted that KFF estimates as many as 3.8 million beneficiaries could be eligible.

The demonstration is temporary. It is set to expire at the end of 2027, and the source said there is no guaranteed coverage after that date. For now, the bridge gives Medicare a limited way to support access while leaving open questions about how durable the benefit will be.

The One Big Beautiful Bill Act turns one as its health care provisions take hold

The second story looked at the One Big Beautiful Bill Act one year after President Trump signed it into law on July 4, 2025. As the law’s health care provisions begin to take effect, the effects are becoming more visible to physicians, practices, and patients.

The Congressional Budget Office estimates that the law’s Medicaid cuts exceed $1 trillion over 10 years and leave roughly 10 million more people uninsured by 2034. The law also directs $50 billion to a rural health fund. According to KFF, that amount offsets only a fraction of an estimated $137 billion in rural Medicaid reductions.

For physicians, payment is one of the most immediate issues. The law includes a one-time 2.5% Medicare increase for 2026, but that increase expires at the end of the year. The AMA says other fee-schedule adjustments already absorb most of it.

Coverage changes are also underway. KFF reported that ACA marketplace enrollment fell about 13% after enhanced subsidies expired at the end of 2025. The administration attributes the decline to its fraud-prevention efforts, while KFF ties it to premium increases.

Medicaid work requirements and more frequent eligibility checks are also scheduled to phase in over the next year. The recap said practices should prepare for more coverage churn and a tighter payer mix heading into 2027. That means physicians may face more variability in whether patients remain covered and how care is paid for, even as the law continues moving from statute into daily practice.

As the U.S. turns 250, a look at how far medicine has come

The final story took a broader historical view as the United States marks its 250th anniversary this Fourth of July. The recap contrasted the medical profession of the founding era with medicine today.

Historians estimate the colonies had only a few thousand physicians, and most were trained by apprenticeship rather than in medical school. The first colonial medical school did not open until 1765. In the founding era, life expectancy at birth is estimated in the high 30s, a figure lowered sharply by infant and child mortality.

Today, the CDC puts U.S. life expectancy at 79.0 years for 2024, which is a record high. Medicine is now a fully credentialed profession shaped by germ theory, antibiotics, and vaccination. The article presents that progress as one of the clearest differences between the early republic and the present day.

Even with those advances, the recap noted that some of the business-of-medicine struggles in 2026 would feel familiar to a physician from 1776. Payment, paperwork, and the challenge of staying independent still shape the work of many physicians. The details have changed, but the sense of ongoing pressure has not entirely gone away.

Taken together, the three stories reflect a profession balancing access, policy, and history. Medicare’s new GLP-1 bridge may help some patients get weight-loss therapy, but it also introduces a new administrative path. The One Big Beautiful Bill Act is now affecting payment and coverage in ways that will continue unfolding over the next year. And the 250-year look back shows how much medicine has improved, even as doctors still navigate questions about reimbursement, regulation, and practice stability.

For physicians, the week’s recap suggests that major change can arrive through many channels at once: a new coverage demonstration, a federal law taking hold, and a milestone anniversary that puts modern medicine in perspective. The common thread is that each development affects how care is delivered, paid for, or understood in the United States.